Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients
- PMID: 19785596
- DOI: 10.1111/j.1365-2133.2009.09472.x
Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients
Abstract
Background Lupus erythematosus (LE) is a chronic, autoimmune disease resulting from an interaction of genetic, environmental and hormonal factors and characterized by a spectrum of clinical forms with variable evolution from a localized cutaneous form to a life-threatening systemic form. Objective To analyse and compare the prevalence and characteristics of the main clinical and immunological manifestations of subacute cutaneous LE (SCLE) and chronic CLE (CCLE). Methods A total of 270 patients with CLE (112 patients with SCLE and 158 patients with CCLE) were studied retrospectively. The clinical and serological characteristics of all the patients were collected in a chart review. Results The patients with SCLE had a higher prevalence of annular and papulosquamous lesions, Raynaud phenomenon, mucous membrane ulcers, malar rashes, photosensitivity, vasculitis and a lower frequency of discoid lesions and alopecia compared with patients with CCLE. Patients with SCLE had a higher prevalence of arthralgias (P < 0.001), xerophthalmia (P = 0.045), arthritis (P < 0.001), nephropathy (P = 0.003) and systemic LE (SLE) (P < 0.001) compared with patients with CCLE. Patients with SCLE also had a higher frequency of laboratory and serological abnormalities than patients with CCLE. Generalized discoid LE (DLE) was associated with a higher prevalence of photosensitivity (P < 0.001), panniculitis (P = 0.009) and SLE (P = 0.003) than localized DLE. In patients with SCLE and those with CCLE, photosensitivity, arthralgias, arthritis, nephropathy and xerophthalmia were associated with SLE. In patients with SCLE, significant correlations existed between clinical and immunological data. Conclusions In our series, differences in the expression of CCLE and SCLE were found with respect to the distribution and type of lesions, systemic features and immunological findings.
Similar articles
-
Cutaneous lupus erythematosus: clinical and immunological study of 308 patients stratified by gender.Clin Exp Dermatol. 2010 Oct;35(7):729-35. doi: 10.1111/j.1365-2230.2009.03764.x. Clin Exp Dermatol. 2010. PMID: 20015282
-
Cutaneous lupus erythematosus: issues in diagnosis and treatment.Am J Clin Dermatol. 2009;10(6):365-81. doi: 10.2165/11310780-000000000-00000. Am J Clin Dermatol. 2009. PMID: 19824738 Review.
-
Cutaneous manifestations of systemic lupus erythematosus.Br J Dermatol. 1996 Sep;135(3):355-62. Br J Dermatol. 1996. PMID: 8949425
-
Drug-induced lupus: an update on its dermatologic aspects.Lupus. 2009 Oct;18(11):935-40. doi: 10.1177/0961203309106176. Lupus. 2009. PMID: 19762393 Review.
-
Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus.Br J Dermatol. 2010 Jan;162(1):64-73. doi: 10.1111/j.1365-2133.2009.09401.x. Epub 2009 Jul 7. Br J Dermatol. 2010. PMID: 19712116
Cited by
-
Coordination of retrotransposons and type I interferon with distinct interferon pathways in dermatomyositis, systemic lupus erythematosus and autoimmune blistering disease.Sci Rep. 2021 Nov 30;11(1):23146. doi: 10.1038/s41598-021-02522-6. Sci Rep. 2021. PMID: 34848794 Free PMC article.
-
B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity.Front Immunol. 2021 Nov 19;12:775353. doi: 10.3389/fimmu.2021.775353. eCollection 2021. Front Immunol. 2021. PMID: 34868043 Free PMC article.
-
Lupus community panel proposals for optimising clinical trials: 2018.Lupus Sci Med. 2018 Mar 23;5(1):e000258. doi: 10.1136/lupus-2018-000258. eCollection 2018. Lupus Sci Med. 2018. PMID: 29657738 Free PMC article. Review.
-
B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus.Ann Rheum Dis. 2021 Sep;80(9):1190-1200. doi: 10.1136/annrheumdis-2021-220349. Epub 2021 Jun 3. Ann Rheum Dis. 2021. PMID: 34083207 Free PMC article.
-
Modulation of Immune Cells as a Therapy for Cutaneous Lupus Erythematosus.Int J Mol Sci. 2022 Sep 14;23(18):10706. doi: 10.3390/ijms231810706. Int J Mol Sci. 2022. PMID: 36142624 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical